Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat.
Inhibitory effects of naturally occurring antioxidants on the initiation stage of hepatocarcinogenesis were studied. Group 1 rats were given a diet containing beta-carotene (beta-CT, 0.02%), alpha-tocopherol (alpha-TP, 1.5%), glutathione (GLT, 5%), vanillin (VNL, 1%), quercetin (QCT, 1%) or ellagic acid (ELA, 1%), or 3 doses of diallyl sulfide (DAS, 200 mg/kg, i.g.) over an 8-day period. On day 7, the animals received a single dose of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ, 100 mg/kg, i.g.), 12 h after two-thirds partial hepatectomy for initiation and 2 weeks thereafter, were placed on promotion regimen comprising phenobarbital (0.05% in diet) and a single dose of D-galactosamine (100 mg/kg, i.p.). Groups 2 and 3 were treated as described for Group 1, but without test material or IQ, respectively. Survivors were killed at week 11 and antioxidant influence was assessed by comparing values for preneoplastic glutathione S-transferase placental form-positive (GST-P+) foci between Groups 1 and 2. All lesions larger than 70 microns in diameter consisting of approximately 5 cells in cross section were counted. Numbers of GST-P+ foci/cm2 in Group 1 were: beta-CT, 7.99; alpha-TP, 8.21; GLT, 9.71; DAS, 10.37; VNL, 10.57; QCT, 11.1; ELA, 12.5 (n = 11-15). All, except ELA, showed a significant decrease as compared with the Group 2 value of 14.54 (n = 15). Only beta-CT showed a significant decrease for the area value. This is the first report to show that beta-CT, alpha-TP, GLT, DAS, VNL, QCT exert inhibitory effects on initiation of hepatocarcinogenesis by the food carcinogen IQ, suggesting that these antioxidants might find application as chemopreventive agents. Furthermore, the current protocol proved practical for the assessment of chemopreventive agents within 11 weeks, a relatively short period.
Chemotherapy Division, National Cancer Center Research Institute, Tokyo.
H
H
Tsuda
N
N
Uehara
Y
Y
Iwahori
M
M
Asamoto
M
M
Iigo
M
M
Nagao
K
K
Matsumoto
M
M
Ito
I
I
Hirono
D000498:Allyl Compounds; D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D001547:Benzaldehydes / Q000627:therapeutic use; D002273:Carcinogens; D002338:Carotenoids / Q000627:therapeutic use; D005506:Food Contamination; D005978:Glutathione / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D011794:Quercetin / Q000627:therapeutic use; D011804:Quinolines; D051381:Rats; D011916:Rats, Inbred F344; D013440:Sulfides / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use; D019207:beta Carotene
D000498:Allyl Compounds; D016588:Anticarcinogenic Agents; D000975:Antioxidants; D001547:Benzaldehydes; D002273:Carcinogens; D011804:Quinolines; D013440:Sulfides; D019207:beta Carotene; D014810:Vitamin E; D002338:Carotenoids; C038491:allyl sulfide; D011794:Quercetin; C100058:vanillin; C036989:2-amino-3,4-dimethylimidazo(4,5-f)quinoline; D005978:Glutathione